A Pharmacovigilance Study of Brain Oedema

Status Completed

Clinical Trial Summary

Literature reports the development of brain oedema following the use of certain drugs. Therefore, this study aims to present a comprehensive disproportionality analysis of brain oedema cases reported to the Food and Drug Administration Adverse Event Reporting System (FAERS).

Clinical Trial Description

Brain oedema is a serious neurological condition, as it possesses a significant impact on the functional abilities of an individual by causing irreversible brain damage and potentiates the risk of mortality. Apart from a number of medical conditions causing brain oedema, evidence suggests the association of various drugs with brain oedema. Therefore, this study aims to provide a comprehensive disproportionality analysis of the drug-induced brain oedema reports in the FAERS database. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04311359
Study type	Observational [Patient Registry]
Source	University of Peshawar
Contact
Status	Completed
Phase
Start date	May 20, 2019
Completion date	November 22, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00409058` - Teen Online Problem Solving (TOPS) - An Online Intervention Following TBI	N/A
Completed	`NCT03323580` - Effects of Intraoperative GDFT on the Postoperative Brain Edema	N/A
Completed	`NCT02368366` - Comparative Effectiveness of Family Problem-Solving Therapy (F-PST) for Adolescent TBI	N/A
Not yet recruiting	`NCT04623307` - Non-contact DCS-Speckle Multi-parameter Imaging for Neurological Diseases
Completed	`NCT00088166` - XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors	Phase 3
Completed	`NCT03957837` - Optical Nerve Sheath Changes During Head Down Laparoscopy
Completed	`NCT02701582` - Goal-Directed Intraoperative Fluid Management Using FloTrac© Monitoring in High-Risk Neurosurgical Patients	N/A
Not yet recruiting	`NCT06307743` - Rapid Local Ischemic Postconditioning in Acute Ischemic Stroke	N/A
Completed	`NCT03573999` - Effect of Mannitol 20% Versus Hypertonic Saline 7.5% in Brain Metabolism and Oxygenation	Phase 4
Terminated	`NCT01369121` - Tolerability Study of Xerecept® in Pediatric Patients	Phase 1/Phase 2
Completed	`NCT05070182` - Resting Energy Needs in Brain Dead Patients (reSting EneRgy nEeds iN brAin DEad Patients)
Completed	`NCT00226655` - An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies	Phase 3
Terminated	`NCT02320955` - Swiss Prospective Autologous Bone Flap Resorption Study
Completed	`NCT02037815` - Correlation of Measured and Calculated Serum Osmolality During Hyperosmolar Drugs Infusion in Patients After Craniotomy	Phase 4
Completed	`NCT02594137` - A Comparison Between Two Techniques for Performing Decompressive Craniectomy	N/A
Withdrawn	`NCT00226668` - XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema	Phase 3
Terminated	`NCT01054404` - Furosemide vs Placebo for Brain Relaxation	N/A
Recruiting	`NCT05622461` - Setting Families on a Positive Path to Recovery After Pediatric TBI: Road-to-Recovery	N/A
Completed	`NCT06327737` - Diabetic Ketoacidosis Diagnosis and Management
Not yet recruiting	`NCT06017635` - Non-invasive Monitoring and Serum Marker Study in Children With Cerebral Edema